0.1140USD+14.11%Mkt Cap: 540018 USDP/E: —Last update: 2026-06-01
ProPhase Labs, Inc. develops and commercializes novel drugs, dietary supplements, and compounds in the United States. It operates through two segments: Diagnostic Services and Consumer Products. The company provides a ra…
Industry Peers
Diagnostics & ResearchIndicators:|
Key Statistics
Company
Market Cap540.02K USD
Enterprise Value9.42M USD
Revenue (TTM)4.90M USD
Gross Profit-150.00K USD
Net Income (TTM)-53.36M USD
Revenue/Share0.5770 USD
Last Price0.1140 USD
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees—
CountryUS
SectorHealthcare
IndustryDiagnostics & Research
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)0.21
PEG—
EV/EBITDA-0.79
EV/Revenue1.92
P/S0.10
P/B0.18
EPS (TTM)-19.80
EPS (Forward)0.48
52W Range
0.07001% of range6.700
52W High6.700 USD
52W Low0.0700 USD
Profitability
Gross Margin-2.22%
Oper. Margin-330.25%
EBITDA Margin-243.08%
Profit Margin-788.24%
ROE-725.74%
ROA-84.44%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-17.54M USD
CapEx (TTM)906.00K USD
FCF Margin876.75%
FCF Yield7955.45%
Net Debt8.53M USD
Net Debt/EBITDA-0.72
Balance Sheet
Debt/Equity3.34
Current Ratio0.11
Quick Ratio0.04
Book Value/Sh0.5460 USD
Cash/Share0.0100 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div DateMay 24, 2022
Pay DateJun 3, 2022
Splits
Last Split1:10
Split DateDec 22, 2025
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.4.74M
Float8.65M
Insiders5.05%
Institutions0.15%
Short Interest
Short Ratio0.1d
Short % Float0.71%
Short % Out.0.65%
Shares Short30.02K
Short (prev mo.)8.96K
Technical
SMA 500.1098 (+3.8%)
SMA 2001.640 (-93.0%)
Beta0.17
S&P 52W Chg27.70%
Avg Vol (30d)40.49K
Avg Vol (10d)17.12K
Technical Indicators
RSI (14)44.9
MACD-0.0083
MACD Signal-0.0051
MACD Hist.-0.0032
BB Upper0.1568 USD
BB Middle0.1171 USD
BB Lower0.0773 USD
BB Width67.85%
ATR (14)0.0249 USD
Vol Ratio (20d)1.19x